{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:24:50Z","timestamp":1790835890168,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T00:00:00Z","timestamp":1416009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Gender-based differences in disease onset in murine models of malignant peripheral nerve sheath tumor (MPNST) and in patients with Neurofibromatosis type-1-(NF-1)-associated or spontaneous MPNST has not been well studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Forty-three <jats:italic>mGFAP-Cre<\/jats:italic>+;<jats:italic>Pten<\/jats:italic>\n              <jats:sup>\n                <jats:italic>loxp<\/jats:italic>\/+<\/jats:sup>;<jats:italic>LSL-K-ras<\/jats:italic>\n              <jats:sup>\n                <jats:italic>G12D<\/jats:italic>\/+<\/jats:sup> mice were observed for tumor development and evaluated for gender disparity in age of MPNST onset. Patient data from the prospectively collected UCLA sarcoma database (1974\u20132011, n\u2009=\u2009113 MPNST patients) and 39 published studies on MPNST patients (n\u2009=\u2009916) were analyzed for age of onset differences between sexes and between NF-1 and spontaneous MPNST patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our murine model showed gender-based differences in MPNST onset, with males developing MPNST significantly earlier than females (142 vs. 162\u00a0days, p\u2009=\u20090.015). In the UCLA patient population, males also developed MPNST earlier than females (median age 35 vs. 39.5\u00a0years, p\u2009=\u20090.048). Patients with NF-1-associated MPNST had significantly earlier age of onset compared to spontaneous MPNST (median age 33 vs. 39\u00a0years, p\u2009=\u20090.007). However, expanded analysis of 916 published MPNST cases revealed no significant age difference in MPNST onset between males and females. Similar to the UCLA dataset, patients with NF-1 developed MPNST at a significantly younger age than spontaneous MPNST patients (p\u2009&lt;\u20090.0001, median age 28 vs. 41\u00a0years) and this disparity was maintained across North American, European, and Asian populations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Although our preclinical model and single-institution patient cohort show gender dimorphism in MPNST onset, no significant gender disparity was detected in the larger MPNST patient meta-dataset. NF-1 patients develop MPNST 13\u00a0years earlier than patients with spontaneous MPNST, with little geographical variance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-14-827","type":"journal-article","created":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T04:14:48Z","timestamp":1416024888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients"],"prefix":"10.1186","volume":"14","author":[{"given":"Elizabeth","family":"Shurell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh M","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen B","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenna M","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Dry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Federman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Tap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz C","family":"Eilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,15]]},"reference":[{"key":"5006_CR1","unstructured":"Exploring the Biological Contributions to Human Health: Does Sex Matter?. 2001, Washington, DC: The National Academies Press"},{"issue":"1","key":"5006_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.envres.2006.09.007","volume":"104","author":"R Benigni","year":"2007","unstructured":"Benigni R: Social sexual inequality and sex difference in cancer incidence. Environ Res. 2007, 104 (1): 128-134.","journal-title":"Environ Res"},{"issue":"4","key":"5006_CR3","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/1055-9965.EPI-08-1118","volume":"18","author":"MB Cook","year":"2009","unstructured":"Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, Devesa SS, McGlynn KA: Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009, 18 (4): 1174-1182.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"19","key":"5006_CR4","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/jnci\/92.19.1560","volume":"92","author":"J McCann","year":"2000","unstructured":"McCann J: Gender differences in cancer that don't make sense\u2013or do they?. J Natl Cancer Inst. 2000, 92 (19): 1560-1562.","journal-title":"J Natl Cancer Inst"},{"key":"5006_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2042-6410-3-3","volume":"3","author":"T Sun","year":"2012","unstructured":"Sun T, Warrington NM, Rubin JB: Why does Jack, and not Jill, break his crown? Sex disparity in brain tumors. Biol Sex Differ. 2012, 3: 3-","journal-title":"Biol Sex Differ"},{"issue":"1","key":"5006_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, et al: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010, 17 (1): 98-110.","journal-title":"Cancer Cell"},{"issue":"3","key":"5006_CR7","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/j.suronc.2013.06.003","volume":"22","author":"J Yang","year":"2013","unstructured":"Yang J, Du X: Genomic and molecular aberrations in malignant peripheral nerve sheath tumor and their roles in personalized target therapy. Surg Oncol. 2013, 22 (3): e53-57.","journal-title":"Surg Oncol"},{"key":"5006_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1471-2407-11-325","volume":"11","author":"R Dubrow","year":"2011","unstructured":"Dubrow R, Darefsky AS: Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007. BMC Cancer. 2011, 11: 325-","journal-title":"BMC Cancer"},{"key":"5006_CR9","volume-title":"J Clin Invest","author":"T Sun","year":"2014","unstructured":"Sun T, Warrington NM, Luo J, Brooks MD, Dahiya S, Snyder SC, Sengupta R, Rubin JB: Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males. J Clin Invest. 2014"},{"issue":"10","key":"5006_CR10","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","volume":"57","author":"BS Ducatman","year":"1986","unstructured":"Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM: Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986, 57 (10): 2006-2021.","journal-title":"Cancer"},{"issue":"3","key":"5006_CR11","first-page":"197","volume":"36","author":"JM McGaughran","year":"1999","unstructured":"McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R, Kingston H, Super M, Harris R, Evans DG: A clinical study of type 1 neurofibromatosis in north west England. J Med Genet. 1999, 36 (3): 197-203.","journal-title":"J Med Genet"},{"issue":"2","key":"5006_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/BF02303627","volume":"2","author":"JN Vauthey","year":"1995","unstructured":"Vauthey JN, Woodruff JM, Brennan MF: Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience. Ann Surg Oncol. 1995, 2 (2): 126-131.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"5006_CR13","first-page":"184","volume":"31","author":"BC Ghosh","year":"1973","unstructured":"Ghosh BC, Ghosh L, Huvos AG, Fortner JG: Malignant schwannoma. A Clinicopathologic Study Cancer. 1973, 31 (1): 184-190.","journal-title":"A Clinicopathologic Study Cancer"},{"issue":"2","key":"5006_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/neuonc\/nos287","volume":"15","author":"M Kolberg","year":"2013","unstructured":"Kolberg M, Holand M, Agesen TH, Brekke HR, Liestol K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA: Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro-Oncology. 2013, 15 (2): 135-147.","journal-title":"Neuro-Oncology"},{"issue":"1","key":"5006_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00427009","volume":"383","author":"JG Guccion","year":"1979","unstructured":"Guccion JG, Enzinger FM: Malignant Schwannoma associated with von Recklinghausen's neurofibromatosis. Virchows Archiv A, Pathol Anatomy Histol. 1979, 383 (1): 43-57.","journal-title":"Virchows Archiv A, Pathol Anatomy Histol"},{"issue":"5","key":"5006_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-2133.1973.tb15445.x","volume":"88","author":"GH Swapp","year":"1973","unstructured":"Swapp GH, Main RA: Neurofibromatosis in pregnancy. Brit J Dermatol. 1973, 88 (5): 431-435.","journal-title":"Brit J Dermatol"},{"issue":"2","key":"5006_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/archinte.1937.00170180126006","volume":"59","author":"RH Sharpe JCaY","year":"1937","unstructured":"Sharpe JCaY RH: Recklinghausen's neurofibromatosis: clinical manifestations in thirty-one cases. Arch Intern Med. 1937, 59 (2): 299-328.","journal-title":"Arch Intern Med"},{"issue":"12","key":"5006_CR18","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/ajmg.a.32301","volume":"146A","author":"TM Roth","year":"2008","unstructured":"Roth TM, Petty EM, Barald KF: The role of steroid hormones in the NF1 phenotype: focus on pregnancy. Am J Med Genet A. 2008, 146A (12): 1624-1633.","journal-title":"Am J Med Genet A"},{"issue":"7","key":"5006_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/mc.20236","volume":"46","author":"L Fishbein","year":"2007","unstructured":"Fishbein L, Zhang X, Fisher LB, Li H, Campbell-Thompson M, Yachnis A, Rubenstein A, Muir D, Wallace MR: In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells. Mol Carcinog. 2007, 46 (7): 512-523.","journal-title":"Mol Carcinog"},{"issue":"8","key":"5006_CR20","doi-asserted-by":"publisher","first-page":"758","DOI":"10.4161\/cbt.10.8.12878","volume":"10","author":"H Li","year":"2010","unstructured":"Li H, Zhang X, Fishbein L, Kweh F, Campbell-Thompson M, Perrin GQ, Muir D, Wallace M: Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells. Cancer Biol Ther. 2010, 10 (8): 758-764.","journal-title":"Cancer Biol Ther"},{"issue":"46","key":"5006_CR21","doi-asserted-by":"publisher","first-page":"19479","DOI":"10.1073\/pnas.0910398106","volume":"106","author":"C Gregorian","year":"2009","unstructured":"Gregorian C, Nakashima J, Dry SM, Nghiemphu PL, Smith KB, Ao Y, Dang J, Lawson G, Mellinghoff IK, Mischel PS, Phelps M, Parada LF, Liu X, Sofroniew MV, Eilber FC, Wu H: PTEN dosage is essential for neurofibroma development and malignant transformation. Proc Natl Acad Sci U S A. 2009, 106 (46): 19479-19484.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11\u201312","key":"5006_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00335-009-9226-1","volume":"20","author":"B Winzen","year":"2009","unstructured":"Winzen B, Koelsch B, Fischer C, Kindler-Rohrborn A: Genetic basis of sex-specific resistance to neuro-oncogenesis in (BDIX x BDIV) F(2) rats. Mamm Genome. 2009, 20 (11\u201312): 741-748.","journal-title":"Mamm Genome"},{"issue":"1","key":"5006_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ijc.21287","volume":"118","author":"BU Koelsch","year":"2006","unstructured":"Koelsch BU, Fischer C, Neibecker M, Schmitt N, Schmidt O, Rajewsky MF, Kindler-Rohrborn A: Gender-specific polygenic control of ethylnitrosourea-induced oncogenesis in the rat peripheral nervous system. Int J Cancer J Int Du Cancer. 2006, 118 (1): 108-114.","journal-title":"Int J Cancer J Int Du Cancer"},{"issue":"10","key":"5006_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1152\/physiolgenomics.00246.2010","volume":"43","author":"B Koelsch","year":"2011","unstructured":"Koelsch B, Winzen-Reichert B, Fischer C, Kutritz A, van den Berg L, Kindler-Rohrborn A: Sex-biased suppression of chemically induced neural carcinogenesis in congenic BDIX.BDIV-Mss4a rats. Physiol Genomics. 2011, 43 (10): 631-639.","journal-title":"Physiol Genomics"},{"issue":"4","key":"5006_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s00335-009-9179-4","volume":"20","author":"JC Walrath","year":"2009","unstructured":"Walrath JC, Fox K, Truffer E, Gregory Alvord W, Quinones OA, Reilly KM: Chr 19(A\/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner. Mamm Genome. 2009, 20 (4): 214-223.","journal-title":"Mamm Genome"},{"issue":"2","key":"5006_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/cncr.24755","volume":"116","author":"MR Benz","year":"2010","unstructured":"Benz MR, Czernin J, Dry SM, Tap WD, Allen-Auerbach MS, Elashoff D, Phelps ME, Weber WA, Eilber FC: Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer. 2010, 116 (2): 451-458.","journal-title":"Cancer"},{"issue":"6","key":"5006_CR27","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/1097-0142(19900915)66:6<1253::AID-CNCR2820660627>3.0.CO;2-R","volume":"66","author":"RH Hruban","year":"1990","unstructured":"Hruban RH, Shiu MH, Senie RT, Woodruff JM: Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer. 1990, 66 (6): 1253-1265.","journal-title":"Cancer"},{"issue":"18","key":"5006_CR28","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1016\/j.ejca.2011.05.031","volume":"47","author":"SHS Ingham","year":"2011","unstructured":"Ingham SHS, Moran A, Wylie J, Leahy M, Evans DG: Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years. Eur J Cancer. 2011, 47 (18): 2723-2728.","journal-title":"Eur J Cancer"},{"key":"5006_CR29","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/1097-0142(196308)16:8<1003::AID-CNCR2820160807>3.0.CO;2-S","volume":"16","author":"AN D'Agostino","year":"1963","unstructured":"D'Agostino AN, Soule EH, Miller RH: Primary malignant neoplasms of nerves (malignant neurilemomas) in patients without manifestations of multiple neurofibromatosis (Von Recklinghausen's disease). Cancer. 1963, 16: 1003-1014.","journal-title":"Cancer"},{"key":"5006_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/1097-0142(196308)16:8<1015::AID-CNCR2820160808>3.0.CO;2-I","volume":"16","author":"AN D'Agostino","year":"1963","unstructured":"D'Agostino AN, Soule EH, Miller RH: Sarcomas of the peripheral nerves and somatic soft tissue associated with multiple neurofibromatosis (Von Recklinghausen's disease). Cancer. 1963, 16: 1015-1027.","journal-title":"Cancer"},{"issue":"3","key":"5006_CR31","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/1097-0142(197103)27:3<720::AID-CNCR2820270331>3.0.CO;2-D","volume":"27","author":"HR White Jr","year":"1971","unstructured":"White HR: Survival in malignant schwannoma. An 18-year study. Cancer. 1971, 27 (3): 720-729.","journal-title":"Cancer"},{"issue":"5","key":"5006_CR32","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/1097-0142(19800901)46:5<1202::AID-CNCR2820460521>3.0.CO;2-5","volume":"46","author":"JQ Trojanowski","year":"1980","unstructured":"Trojanowski JQ, Kleinman GM, Proppe KH: Malignant tumors of nerve sheath origin. Cancer. 1980, 46 (5): 1202-1212.","journal-title":"Cancer"},{"issue":"1","key":"5006_CR33","first-page":"57","volume":"14","author":"O Arpornchayanon","year":"1984","unstructured":"Arpornchayanon O, Hirota T, Itabashi M, Nakajima T, Fukuma H, Beppu Y, Nishikawa K: Malignant peripheral nerve tumors: a clinicopathological and electron microscopic study. Jpn J Clin Oncol. 1984, 14 (1): 57-74.","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"5006_CR34","first-page":"147","volume":"92","author":"M Bojsen-Moller","year":"1984","unstructured":"Bojsen-Moller M, Myhre-Jensen O: A consecutive series of 30 malignant schwannomas. Survival in relation to clinico-pathological parameters and treatment. Acta Pathol Microbiol Immunol Scand A. 1984, 92 (3): 147-155.","journal-title":"Acta Pathol Microbiol Immunol Scand A"},{"issue":"6","key":"5006_CR35","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/1097-0142(19840915)54:6<1049::AID-CNCR2820540620>3.0.CO;2-1","volume":"54","author":"BS Ducatman","year":"1984","unstructured":"Ducatman BS, Scheithauer BW: Malignant peripheral nerve sheath tumors with divergent differentiation. Cancer. 1984, 54 (6): 1049-1057.","journal-title":"Cancer"},{"issue":"6","key":"5006_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/00000478-198506000-00005","volume":"9","author":"Y Daimaru","year":"1985","unstructured":"Daimaru Y, Hashimoto H, Enjoji M: Malignant peripheral nerve-sheath tumors (malignant schwannomas). An immunohistochemical study of 29 cases. Am J Surg Pathol. 1985, 9 (6): 434-444.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"5006_CR37","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1288\/00005537-199110000-00003","volume":"101","author":"JW Bailet","year":"1991","unstructured":"Bailet JW, Abemayor E, Andrews JC, Rowland JP, Fu YS, Dawson DE: Malignant nerve sheath tumors of the head and neck: a combined experience from two university hospitals. Laryngoscope. 1991, 101 (10): 1044-1049.","journal-title":"Laryngoscope"},{"issue":"6","key":"5006_CR38","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/BF02307086","volume":"2","author":"JM de Cou","year":"1995","unstructured":"de Cou JM, Rao BN, Parham DM, Lobe TE, Bowman L, Pappo AS, Fontanesi J: Malignant peripheral nerve sheath tumors: the St. Jude Children's Research Hospital experience. Ann Surg Oncol. 1995, 2 (6): 524-529.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"5006_CR39","first-page":"87","volume":"51","author":"T Kunisada","year":"1997","unstructured":"Kunisada T, Kawai A, Ozaki T, Sugihara S, Taguchi K, Inoue H: A clinical analysis of malignant schwannoma. Acta Med Okayama. 1997, 51 (2): 87-92.","journal-title":"Acta Med Okayama"},{"issue":"1","key":"5006_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00006123-199807000-00035","volume":"43","author":"L Angelov","year":"1998","unstructured":"Angelov L, Davis A, O'Sullivan B, Bell R, Guha A: Neurogenic sarcomas: experience at the University of Toronto. Neurosurgery. 1998, 43 (1): 56-64. discussion 64-55","journal-title":"Neurosurgery"},{"issue":"11","key":"5006_CR41","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2191::AID-CNCR14>3.0.CO;2-P","volume":"82","author":"HP Kourea","year":"1998","unstructured":"Kourea HP, Bilsky MH, Leung DH, Lewis JJ, Woodruff JM: Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors. Cancer. 1998, 82 (11): 2191-2203.","journal-title":"Cancer"},{"issue":"6","key":"5006_CR42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/00043426-199911000-00011","volume":"21","author":"M Casanova","year":"1999","unstructured":"Casanova M, Ferrari A, Spreafico F, Luksch R, Terenziani M, Cefalo G, Massimino M, Gandola L, Lombardi F, Fossati-Bellani F: Malignant peripheral nerve sheath tumors in children: a single-institution twenty-year experience. J Pediatr Hematol Oncol. 1999, 21 (6): 509-513.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"5006_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s100249900138","volume":"2","author":"H Liapis","year":"1999","unstructured":"Liapis H, Marley EF, Lin Y, Dehner LP: p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children. Pediatr Dev Pathol. 1999, 2 (4): 377-384.","journal-title":"Pediatr Dev Pathol"},{"issue":"2","key":"5006_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0304-3835(00)00426-2","volume":"155","author":"H Schmidt","year":"2000","unstructured":"Schmidt H, Taubert H, Meye A, Wurl P, Bache M, Bartel F, Holzhausen HJ, Hinze R: Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease. Cancer Lett. 2000, 155 (2): 181-190.","journal-title":"Cancer Lett"},{"issue":"3","key":"5006_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/(SICI)1098-2264(199907)25:3<205::AID-GCC2>3.0.CO;2-B","volume":"25","author":"H Schmidt","year":"1999","unstructured":"Schmidt H, Wurl P, Taubert H, Meye A, Bache M, Holzhausen HJ, Hinze R: Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant. Genes Chromosomes Cancer. 1999, 25 (3): 205-211.","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"5006_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jnnp.68.3.353","volume":"68","author":"RE Ferner","year":"2000","unstructured":"Ferner RE, Lucas JD, O'Doherty MJ, Hughes RA, Smith MA, Cronin BF, Bingham J: Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry. 2000, 68 (3): 353-357.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"5006_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/(SICI)1096-9896(200001)190:1<31::AID-PATH505>3.0.CO;2-#","volume":"190","author":"F Mertens","year":"2000","unstructured":"Mertens F, Dal Cin P, De Wever I, Fletcher CD, Mandahl N, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, van Den Berghe H, Vanni R, Will\u00e9n H: Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol. 2000, 190 (1): 31-38.","journal-title":"J Pathol"},{"issue":"7","key":"5006_CR48","first-page":"908","volume":"137","author":"K Leroy","year":"2001","unstructured":"Leroy K, Dumas V, Martin-Garcia N, Falzone MC, Voisin MC, Wechsler J, Revuz J, Creange A, Levy E, Lantieri L, Zeller J, Wolkenstein P: Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. Arch Dermatol. 2001, 137 (7): 908-913.","journal-title":"Arch Dermatol"},{"issue":"5","key":"5006_CR49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/jmg.39.5.311","volume":"39","author":"DG Evans","year":"2002","unstructured":"Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A: Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 2002, 39 (5): 311-314.","journal-title":"J Med Genet"},{"issue":"10","key":"5006_CR50","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/00000478-200310000-00006","volume":"27","author":"H Zhou","year":"2003","unstructured":"Zhou H, Coffin CM, Perkins SL, Tripp SR, Liew M, Viskochil DH: Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle\/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. Am J Surg Pathol. 2003, 27 (10): 1337-1345.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"5006_CR51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1750-3639.2004.tb00067.x","volume":"14","author":"MA Watson","year":"2004","unstructured":"Watson MA, Perry A, Tihan T, Prayson RA, Guha A, Bridge J, Ferner R, Gutmann DH: Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors. Brain Pathol. 2004, 14 (3): 297-303.","journal-title":"Brain Pathol"},{"issue":"2","key":"5006_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1212\/01.wnl.0000168830.79997.13","volume":"65","author":"T Tucker","year":"2005","unstructured":"Tucker T, Wolkenstein P, Revuz J, Zeller J, Friedman JM: Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology. 2005, 65 (2): 205-211.","journal-title":"Neurology"},{"issue":"4","key":"5006_CR53","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00259-005-0030-1","volume":"33","author":"W Brenner","year":"2006","unstructured":"Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, Buchert R, Clausen M, Mautner VF: Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. Eur J Nucl Med Mol Imaging. 2006, 33 (4): 428-432.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"5006_CR54","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/humu.9429","volume":"27","author":"M Upadhyaya","year":"2006","unstructured":"Upadhyaya M, Spurlock G, Majounie E, Griffiths S, Forrester N, Baser M, Huson SM, Gareth Evans D, Ferner R: The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs). Hum Mutat. 2006, 27 (7): 716-","journal-title":"Hum Mutat"},{"issue":"8","key":"5006_CR55","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1593\/neo.07304","volume":"9","author":"N Holtkamp","year":"2007","unstructured":"Holtkamp N, Atallah I, Okuducu AF, Mucha J, Hartmann C, Mautner VF, Friedrich RE, Mawrin C, von Deimling A: MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors. Neoplasia. 2007, 9 (8): 671-677.","journal-title":"Neoplasia"},{"issue":"5","key":"5006_CR56","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/hed.20537","volume":"29","author":"A Minovi","year":"2007","unstructured":"Minovi A, Basten O, Hunter B, Draf W, Bockmuhl U: Malignant peripheral nerve sheath tumors of the head and neck: management of 10 cases and literature review. Head Neck. 2007, 29 (5): 439-445.","journal-title":"Head Neck"},{"key":"5006_CR57","doi-asserted-by":"publisher","first-page":"849156","DOI":"10.1155\/2008\/849156","volume":"2008","author":"S Tabone-Eglinger","year":"2008","unstructured":"Tabone-Eglinger S, Bahleda R, Cote JF, Terrier P, Vidaud D, Cayre A, Beauchet A, Theou-Anton N, Terrier-Lacombe MJ, Lemoine A, Penault-Llorca F, Le Cesne A, Emile JF: Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs. Sarcoma. 2008, 2008: 849156-","journal-title":"Sarcoma"},{"issue":"1","key":"5006_CR58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/humu.20601","volume":"29","author":"M Upadhyaya","year":"2008","unstructured":"Upadhyaya M, Kluwe L, Spurlock G, Monem B, Majounie E, Mantripragada K, Ruggieri M, Chuzhanova N, Evans DG, Ferner R, Thomas N, Guha A, Mautner V: Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). Hum Mutat. 2008, 29 (1): 74-82.","journal-title":"Hum Mutat"},{"issue":"5","key":"5006_CR59","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1215\/15228517-2008-127","volume":"11","author":"HR Brekke","year":"2009","unstructured":"Brekke HR, Kolberg M, Skotheim RI, Hall KS, Bjerkehagen B, Risberg B, Domanski HA, Mandahl N, Liestol K, Smeland S, Danielsen HE, Mertens F, Lothe RA: Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors. Neuro-Oncology. 2009, 11 (5): 514-528.","journal-title":"Neuro-Oncology"},{"issue":"9","key":"5006_CR60","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1200\/JCO.2009.24.8989","volume":"28","author":"HR Brekke","year":"2010","unstructured":"Brekke HR, Ribeiro FR, Kolberg M, Agesen TH, Lind GE, Eknaes M, Hall KS, Bjerkehagen B, van den Berg E, Teixeira MR, Mandahl N, Smeland S, Mertens F, Skotheim RI, Lothe RA: Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group. J Clin Oncol. 2010, 28 (9): 1573-1582.","journal-title":"J Clin Oncol"},{"issue":"4","key":"5006_CR61","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4103\/0377-4929.71998","volume":"53","author":"B Rekhi","year":"2010","unstructured":"Rekhi B, Ingle A, Kumar R, DeSouza MA, Dikshit R, Jambhekar NA: Malignant peripheral nerve sheath tumors: clinicopathological profile of 63 cases diagnosed at a tertiary cancer referral center in Mumbai. India Indian J Pathol Microbiol. 2010, 53 (4): 611-618.","journal-title":"India Indian J Pathol Microbiol"},{"issue":"1","key":"5006_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/path.2633","volume":"220","author":"S Subramanian","year":"2010","unstructured":"Subramanian S, Thayanithy V, West RB, Lee CH, Beck AH, Zhu S, Downs-Kelly E, Montgomery K, Goldblum JR, Hogendoorn PC, Corless CL, Oliveira AM, Dry SM, Nielsen TO, Rubin BP, Fletcher JA, Fletcher CD, van de Rijn M: Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol. 2010, 220 (1): 58-70.","journal-title":"J Pathol"},{"issue":"12","key":"5006_CR63","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/gcc.20921","volume":"50","author":"E Beert","year":"2011","unstructured":"Beert E, Brems H, Daniels B, De Wever I, Van Calenbergh F, Schoenaers J, Debiec-Rychter M, Gevaert O, De Raedt T, Van Den Bruel A, de Ravel T, Cichowski K, Kluwe L, Mautner V, Sciot R, Legius E: Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Genes Chromosomes Cancer. 2011, 50 (12): 1021-1032.","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"5006_CR64","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/DAD.0b013e31820dfcbf","volume":"33","author":"JG Pryor","year":"2011","unstructured":"Pryor JG, Brown-Kipphut BA, Iqbal A, Scott GA: Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor. Am J Dermatopathol. 2011, 33 (8): 780-785.","journal-title":"Am J Dermatopathol"},{"issue":"24","key":"5006_CR65","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.1158\/1078-0432.CCR-11-1707","volume":"17","author":"J Yang","year":"2011","unstructured":"Yang J, Ylipaa A, Sun Y, Zheng H, Chen K, Nykter M, Trent J, Ratner N, Lev DC, Zhang W: Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment. Clin Cancer Res. 2011, 17 (24): 7563-7573.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"5006_CR66","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1158\/1078-0432.CCR-10-1551","volume":"17","author":"J Yu","year":"2011","unstructured":"Yu J, Deshmukh H, Payton JE, Dunham C, Scheithauer BW, Tihan T, Prayson RA, Guha A, Bridge JA, Ferner RE, Lindberg GM, Gutmann RJ, Emnett RJ, Salavaggione L, Gutmann DH, Nagarajan R, Watson MA, Perry A: Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clin Cancer Res. 2011, 17 (7): 1924-1934.","journal-title":"Clin Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-827.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-827\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-827.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:30:09Z","timestamp":1630564209000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,15]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5006"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-827","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,15]]},"assertion":[{"value":"22 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"827"}}